National Institutes of Health

Description

-Purpose. Scientific cooperation between India and the U.S. has taken place under a variety of bilateral umbrella agreements, including the Indo-U.S. Science and Technology (S and T) Sub-Commission, the Gandhi-Reagan S and T Initiative, the U.S.-India Fund, and the current S and T Cooperation Agreement. Building upon these agreements and initiatives, representatives of the United States and the Government of India signed a Memorandum of Understanding on July, 9 1987 implementing the Indo-U.S. Vaccine Action Program (VAP) in order to expand collaborative vaccine research. The goal of the VAP is to support collaborative vaccine-related research projects that ultimately reduce the burden of infectious diseases of importance in India, the U.S., the South Asian region and globally. -Mechanism of Support. This funding opportunity announcement (FOA) solicits Small Research Grant (R03) applications, which will provide U.S. dollar support of vaccine-related research in India and the United States and augment current VAP activities. Investigators from U.S. and Indian institutions are eligible to apply. -Applications are solicited from organizations/institutions that propose to conduct vaccine-related research through well-established collaborations with Indian investigators on the following: dengue, influenza (including avian influenza), HIV/AIDS, and tuberculosis.

Who can apply

• State governments
• Public and State controlled institutions of higher education
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV